Modulating Intramuscular Fat Infiltration by Small Molecules

Abstract

Skeletal muscle has a remarkable ability to regenerate upon injury. However, during aging and in diseases such as muscular dystrophies and diabetes, muscle tissue is replaced by fibrotic scar and fat tissue in a process called fatty fibrosis. Currently, there are no known treatments to prevent fatty fibrosis or the decline in muscle mass and function. Our lab and others have shown that ectopic activation of the Hedgehog (Hh) pathway accelerated muscle regeneration after an acute injury and preserved muscle function with age and disease. In addition, our lab demonstrated that Hh is a potent anti‐adipogenic signal and that activating Hh prevents intramuscular fat formation. However, the cellular and molecular mechanisms by which Hh balances fatty fibrosis and muscle regeneration are unclear. In this project, we use small molecules as a novel approach for modulating intramuscular fat infiltration via Hh signaling: Smoothened agonist (SAG) to activate and Vismodegib to inactivate Hh. We found that SAG (HHON) successfully activates the Hh pathway while Vismodegib (HHOFF) inactivates the pathway, as detected by RT‐qPCR analysis for the expression of key Hh target gene Gli1. Excitingly, by modulating the Hh pathway, SAG and Vismodegib decreased and increased fat infiltration, respectively. We are currently evaluating the effects of SAG and Vismodegib administration on muscle regeneration and fibrosis. Future experiments will focus on using small molecules to modulate the Hh pathway at different time points after injury, as well as looking to therapeutic applications in treating fatty fibrosis in conditions such as Duchenne muscular dystrophy. Together, the results of this project will help uncover the regulatory role and dynamics of Hh signaling in intramuscular fat infiltration, ultimately providing a starting point for developing powerful new therapeutics to treat fatty fibrosis.